Liver International logo Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 27, Number 9, November 2007

< previous issue | all issues | next issue >

Treating nonalcoholic fatty liver disease
pp. 1157-1165(9)
Authors: Méndez-Sánchez, Nahum; Arrese, Marco; Zamora-Valdés, Daniel; Uribe, Misael

Percutaneous liver biopsy in clinical practice
pp. 1166-1173(8)
Authors: Al Knawy, Bandar; Shiffman, Mitchell

Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis
pp. 1174-1184(11)
Authors: Itatsu, Keita; Zen, Yoh; Ohira, Shusaku; Ishikawa, Akira; Sato, Yasunori; Harada, Kenichi; Ikeda, Hiroko; Sasaki, Motoko; Nimura, Yuji; Nakanuma, Yasuni

Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials
pp. 1185-1193(9)
Authors: Rudin, Dan; Shah, Sooraj M.; Kiss, Alexander; Wetz, Robert V.; Sottile, Vincent M.

Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis
pp. 1194-1201(8)
Authors: Kalaitzakis, Evangelos; Olsson, Rolf; Henfridsson, Pia; Hugosson, Irene; Bengtsson, Maria; Jalan, Rajiv; Björnsson, Einar

Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients
pp. 1202-1208(7)
Authors: Jiang, Zhijun; Feng, Xiaoning; Zhang, Wu; Gao, Feng; Ling, Qi; Zhou, Lin; Xie, Haiyang; Chen, Qixing; Zheng, Shusen

Similar effects of recombinant interferon-α-2b and natural interferon-α when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma
pp. 1209-1216(8)
Authors: Uka, Kiminori; Aikata, Hiroshi; Takaki, Shintaro; Miki, Daiki; Jeong, Soo Cheol; Hiramatsu, Akira; Kodama, Hideaki; Shirakawa, Hiroo; Kawakami, Yoshiiku; Takahashi, Shoichi; Toyota, Naoyuki; Ito, Katsuhide; Chayama, Kazuaki

γ-Glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-α-2b in chronic hepatitis C non-responders
pp. 1217-1225(9)
Authors: Bergmann, Jilling F.; Vrolijk, Jan M.; van der Schaar, Peter; Vroom, Brigitte; van Hoek, Bart; van der Sluys Veer, Annet; de Vries, Richard A.; Verhey, Elke; Hansen, Bettina E.; Brouwer, Johannes T.; Janssen, Harry L. A.; Schalm, Solko W.; de Knegt, Robert J.

Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis
pp. 1226-1231(6)
Authors: Rigopoulou, Eirini I.; Davies, Edward T.; Bogdanos, Dimitrios-Petrou; Liaskos, Christos; Mytilinaiou, Maria; Koukoulis, George K.; Dalekos, George N.; Vergani, Diego

Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension
pp. 1232-1239(8)
Authors: Kemp, William; Krum, Henry; Colman, John; Bailey, Michael; Yandle, Tim; Richards, Mark; Roberts, Stuart

Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation
pp. 1240-1248(9)
Authors: Perry, John F.; Charlton, Barbara; Koorey, David J.; Waugh, Richard C.; Gallagher, P. James; Crawford, Michael D.; Verran, Deborah J.; McCaughan, Geoffrey W.; Strasser, Simone I.

Glycine reduces hepatic warm ischaemia-reperfusion injury by suppressing inflammatory reactions in rats
pp. 1249-1254(6)
Authors: Yamanouchi, Kosho; Eguchi, Susumu; Kamohara, Yukio; Yanaga, Katsuhiko; Okudaira, Sadayuki; Tajima, Yoshitsugu; Kanematsu, Takashi

Hepatic stellate cell line modulates lipogenic transcription factors
pp. 1255-1264(10)
Authors: Guimarães, Eduardo L. M.; Franceschi, Mariana F. S.; Andrade, Cláudia M. B.; Guaragna, Regina M.; Borojevic, Radovan; Margis, Rogério; Bernard, Elena A.; Guma, Fátima C. R.

Leptin stimulates α1(I) collagen expression in human hepatic stellate cells via the phosphatidylinositol 3-kinase/Akt signalling pathway
pp. 1265-1272(8)
Authors: Niu, Liwen; Wang, Xiaohong; Li, Jun; Huang, Yan; Yang, Zhen; Chen, Feihu; Ni, Hongchang; Jin, Yong; Lu, Xiongwen; Cao, Qi

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells
pp. 1273-1281(9)
Authors: Kohjima, Motoyuki; Enjoji, Munechika; Higuchi, Nobito; Kotoh, Kazuhiro; Kato, Masaki; Takayanagi, Ryoiichi; Nakamuta, Makoto

Successful living donor liver transplantation using a graft from a hepatitis B surface antigen-positive donor
pp. 1282-1286(5)
Authors: Soejima, Yuji; Shimada, Mitsuo; Taketomi, Akinobu; Yoshizumi, Tomoharu; Uchiyama, Hideaki; Ikegami, Toru; Nakamuta, Makoto; Maehara, Yoshihiko

Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: report of two cases
pp. 1287-1292(6)
Authors: Kawaguchi, Takumi; Taniguchi, Eitaro; Itou, Minoru; Sumie, Shuji; Oriishi, Tetsuharu; Matsuoka, Hisako; Nagao, Yumiko; Sata, Michio

Perivascular epithelioid cell tumour of the liver
pp. 1293-1294(2)
Authors: Fang, Songhua; Zhou, Lina; Jin, Mei; Hu, Jibo

Announcement
pp. 1295-1295(1)

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page